IS8301A - New Fusic Acid Derivatives - Google Patents

New Fusic Acid Derivatives

Info

Publication number
IS8301A
IS8301A IS8301A IS8301A IS8301A IS 8301 A IS8301 A IS 8301A IS 8301 A IS8301 A IS 8301A IS 8301 A IS8301 A IS 8301A IS 8301 A IS8301 A IS 8301A
Authority
IS
Iceland
Prior art keywords
new
acid derivatives
fusic
fusic acid
derivatives
Prior art date
Application number
IS8301A
Other languages
Icelandic (is)
Inventor
Duvold Tori
Aage Svensgaard Bretting Claus
Rødbroe Rasmussen Poul
Maud Elysa Bouérat Duvold Laetitia
Thorhauge Jacob
Original Assignee
Leo Pharma A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/DK2004/000491 external-priority patent/WO2005007669A1/en
Application filed by Leo Pharma A/S filed Critical Leo Pharma A/S
Publication of IS8301A publication Critical patent/IS8301A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/002Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 13 (17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS8301A 2003-07-16 2006-02-14 New Fusic Acid Derivatives IS8301A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200301080 2003-07-16
US48760903P 2003-07-17 2003-07-17
DKPA200301486 2003-10-09
PCT/DK2004/000491 WO2005007669A1 (en) 2003-07-16 2004-07-09 Novel fusidic acid derivatives

Publications (1)

Publication Number Publication Date
IS8301A true IS8301A (en) 2006-02-14

Family

ID=34084106

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8301A IS8301A (en) 2003-07-16 2006-02-14 New Fusic Acid Derivatives

Country Status (6)

Country Link
KR (1) KR20060091290A (en)
IL (1) IL172699A0 (en)
IS (1) IS8301A (en)
MX (1) MXPA06000423A (en)
NO (1) NO20060614L (en)
TW (1) TW200510447A (en)

Also Published As

Publication number Publication date
KR20060091290A (en) 2006-08-18
TW200510447A (en) 2005-03-16
MXPA06000423A (en) 2006-04-05
IL172699A0 (en) 2006-04-10
NO20060614L (en) 2006-02-08

Similar Documents

Publication Publication Date Title
ATE427296T1 (en) PHENOXYACETIC ACID DERIVATIVES
ATE340782T1 (en) PIPERIDINEBENZENESULFONAMIDE DERIVATIVES
ATE383329T1 (en) BIARYLOXYMETHYLARENECARBONIC ACID
ATE352550T1 (en) CHINAZOLINE DERIVATIVES
DK1682493T3 (en) Amidoacetonitrile derivatives
DK1692242T3 (en) Viscoelastic acid
ATE478870T1 (en) SPIROINDOLINEPIPERIDEDINE DERIVATIVES
ATE460418T1 (en) HETEROCYCLOCARBOXAMIDE DERIVATIVES
ATE450506T1 (en) INDOLE-3-SULFUR DERIVATIVES
ATE467631T1 (en) QUINUCLIDINAMIDE DERIVATIVES
ATE438644T1 (en) CHINAZOLINE DERIVATIVES
IS7720A (en) Piperidine-N-oxide derivatives
DK1474408T3 (en) N-phenyl-2-pyrimidineamine derivatives
IS8439A (en) New quinoline derivatives
DK1606277T3 (en) Imidazol-4-yl-ethynyl-pyridine derivatives
IS2656B (en) New besimidasol derivatives
ATE335729T1 (en) 3H-CHINAZOLINE -4-ONE DERIVATIVES
ATE354365T1 (en) N-THIAZOLE-2-YL-BENZAMIDE DERIVATIVES
ATE423771T1 (en) TETRAHYDROCHINOLINE DERIVATIVES
DK1706373T3 (en) Amidoacetonitrile derivatives
DE60324703D1 (en) BARBITIC ACID DERIVATIVES.
IS8045A (en) Purin-6-one derivatives
DE50306277D1 (en) 4-alkyl- / 4-alkenyl- / 4-alkynylmethyl / -1-arylcyclohexylamine DERIVATIVES
ATE444953T1 (en) SUBSTITUTED SPIROBENZAZEPINES
IS8301A (en) New Fusic Acid Derivatives